Whole inactivated SIV vaccine grown on human cells fails to protect against homologous SIV grown on simian cells.
AI Summary
Key Findings
Abstract
Several groups have reported protection against experimental SIV infection in macaques immunized with a whole inactivated virus vaccine. The aim of the current study was to investigate whether five macaques vaccinated with whole inactivated SIV and previously shown to be protected against challenge with two divergent strains of SIV grown on human cells could resist challenge with a subsequent homologous SIV grown on macaque cells. We show here that this same vaccine did not protect when the challenge virus was grown on primary cells of monkey origin.
Affiliation
Department of Immunology, National Bacteriological Laboratory, Stockholm, Sweden.
External References
- PubMed ID:
- 8411101
Comments
Sign in or create a free account to join the conversation.
Sign in to commentBe the first to comment.